Abstract:c-Myc is an oncogene involved in many forms of cancer. Proteomic analysis of human P-493 B lymphoma cells and PC3 prostate cancer cells shows that c-Myc regulates the microRNAs miR-23a and miR-23b to increase the expression of the mitochondrial enzyme glutaminase. This leads to enhanced glutamine metabolism and contributes to the metabolic changes in Myc-driven cancers. This paper shows that c-Myc regulates the microRNAs miR-23a and miR-23b to increase the expression of the mitochondrial enzyme glutaminase. This leads to enhanced glutamine metabolism and contributes to the metabolic changes in c-Myc-driven cancers. Altered glucose metabolism in cancer cells is termed the Warburg effect, which describes the propensity of most cancer cells to take up glucose avidly and convert it primarily to lactate, despite available oxygen1,2. Notwithstanding the renewed interest in the Warburg effect, cancer cells also depend on continued mitochondrial function for metabolism, specifically glutaminolysis that catabolizes glutamine to generate ATP and lactate3. Glutamine, which is highly transported into proliferating cells4,5, is a major source of energy and nitrogen for biosynthesis, and a carbon substrate for anabolic processes in cancer cells, but the regulation of glutamine metabolism is not well understood1,6. Here we report that the c-Myc (hereafter referred to as Myc) oncogenic transcription factor, which is known to regulate microRNAs7,8 and stimulate cell proliferation9, transcriptionally represses miR-23a and miR-23b, resulting in greater expression of their target protein, mitochondrial glutaminase, in human P-493 B lymphoma cells and PC3 prostate cancer cells. This leads to upregulation of glutamine catabolism10. Glutaminase converts glutamine to glutamate, which is further catabolized through the tricarboxylic acid cycle for the production of ATP or serves as substrate for glutathione synthesis11. The unique means by which Myc regulates glutaminase uncovers a previously unsuspected link between Myc regulation of miRNAs, glutamine metabolism, and energy and reactive oxygen species homeostasis.

C-Myc Negatively Controls the Tumor Suppressor PTEN by Upregulating Mir-26A in Glioblastoma Multiforme Cells

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

MIR517C Inhibits Autophagy and the Epithelial-to-mesenchymal (-Like) Transition Phenotype in Human Glioblastoma Through KPNA2-dependent Disruption of TP53 Nuclear Translocation.

Mir-338-3p Functions As a Tumor Suppressor in Gastric Cancer by Targeting PTP1B

Mir-1258 Attenuates Tumorigenesis Through Targeting E2F1 to Inhibit PCNA and MMP2 Transcription in Glioblastoma.

Neurotensin Signaling Stimulates Glioblastoma Cell Proliferation By Upregulating C-Myc And Inhibiting Mir-29b-1 And Mir-129-3p

The Mir-92B Functions As a Potential Oncogene by Targeting on Smad3 in Glioblastomas

C-Myc Suppression of Mir-23A/b Enhances Mitochondrial Glutaminase Expression and Glutamine Metabolism.

Mir-484/Map2/c-myc-positive Regulatory Loop in Glioma Promotes Tumor-Initiating Properties Through ERK1/2 Signaling

miR-708 acts as a tumor suppressor in human glioblastoma cells.

Mir-26A and Mir-26B Inhibit Esophageal Squamous Cancer Cell Proliferation Through Suppression of C-Myc Pathway

Mir-4295 Promotes the Malignant Progression of Gastric Cancer Via Targeting PTEN.

MiR-188-3p/GPR26 Modulation Functions As a Potential Regulator in Manipulating Glioma Cell Properties

GTF2E2 Downregulated by Mir-340-5p Inhibits the Malignant Progression of Glioblastoma

MiR-449a Exerts Tumor-Suppressive Functions in Human Glioblastoma by Targeting Myc-associated Zinc-Finger Protein.

CSIG-28. LONG NONCODING RNA MIR22 HOST GENE-DERIVED miR-22-3p AND miR-22-5p PROMOTE PROLIFERATION, INVASION AND SELF-RENEWAL IN HUMAN GLIOMAS VIA Wnt/-CATENIN SIGNALING

Mir-145-5p Inhibits the Proliferation of Glioma Stem Cells by Targeting Translationally Controlled Tumor Protein.

Mir-29A Sensitizes the Response of Glioma Cells to Temozolomide by Modulating the P53/MDM2 Feedback Loop.

Mir-429 Modulates the Expression of C-Myc in Human Gastric Carcinoma Cells.

MiR-19b and Mir-20A Suppress Apoptosis, Promote Proliferation and Induce Tumorigenicity of Multiple Myeloma Cells by Targeting PTEN.

Next Generation Sequencing Analysis of Mirnas: MiR-127-3p Inhibits Glioblastoma Proliferation and Activates TGF-β Signaling by Targeting SKI